MagForce AG: MagForce USA, Inc. receives Payment Code Approval by the American Medical Association for the Focal Ablation of Prostate Cancer with the NanoTherm Therapy System Written by Andreas Villaester on 8th April 2022. Posted in Client News. Previous Next